Remove Clinical Development Remove Clinical Supply Remove Pharmaceuticals
article thumbnail

[Webinar] How biotech companies can improve clinical supply planning and distrib…

The Pharma Data

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

article thumbnail

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

The Pharma Data

Management of the Company believe that the proposed acquisition will strengthen PharmaDrug’s product pipeline, intellectual property portfolio and pharmaceutical development expertise. Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Molecular Partners Announces Collaboration With Novartis to Develop Two DARPin(R) Therapies Designed for Potential Use Against COVID-19

The Pharma Data

Under the agreement, during the option period, Molecular Partners will conduct Phase 1 clinical trials for MP0420, expected to begin in November 2020, and perform all remaining preclinical work for MP0423 and Novartis will conduct Phase 2 and Phase 3 clinical trials, with Molecular Partners as sponsor of these trials.

article thumbnail

The golden era of GLP-1 drugs: How will it impact medicine and society?

BioPharma Drive: Drug Pricing

Also, we should not rely solely on pharmaceuticals to address the root causes of systemic health issues. These drugs could drastically lower rates of many life-affecting diseases and ailments, such as diabetes, cardiovascular disease and other metabolic disorders and contribute to improving millions of lives.

article thumbnail

[Podcast] Trial Trailblazers: Behind clinical breakthroughs

BioPharma Drive: Drug Pricing

But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Trials 130
article thumbnail

FDA’s AI tool ‘Elsa’ is here, and the industry has questions

BioPharma Drive: Drug Pricing

“I find it very exciting as well as surprising that the FDA is putting their foot on the gas in terms of helping roll out AI internally within the agency, because it actually aligns quite nicely with the adoption speed that were seeing within the pharmaceutical manufacturing side of the table,” Feiger said.

FDA 130
article thumbnail

Transforming cancer care through clinical excellence

Drug Target Review

I worked to continually grow my expertise, responsibility, and leadership before ultimately taking on my current role as Senior Vice President and Global Head of Clinical Operations at BeOne. My proudest achievement is my leadership journey building legacy organisations, processes and tools in clinical operations.